4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-000175
President and COO sold 8,000 shares at $10.58 ($84,654)
- President and COO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Larson Tina Marriott · President and COO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,000 | $1.06 | $8,480 | 422,548 | D |
| 2023-12-28 | Sale : show line 2 in the form 10b5-1 | −8,000 | $10.58 | $84,654 | 414,548 | D |
| Open-market sales · 8,000 sh · avg $10.58 · $84,654 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-12-28 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −8,000 | $1.06 | 2028-07-22 | 8,000 | 512,000 | D |
Loading xslF345X05/doc4.xml…